跳至主要内容
临床试验/ACTRN12616001654448
ACTRN12616001654448进行中(未招募)3 期

A randomised controlled non-inferiority clinical trial to evaluate the cost-effectiveness and safety of cytisine compared to varenicline as a treatment for people who wish to stop smoking

niversity of New South Wales0 个研究点目标入组 1,452 人开始时间: 2016年11月30日最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
1,452

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants will be at least 18 years of age; current daily smoker; motivated and willing to make a quit attempt using medications (cytisine/varenicline); able to provide informed consent; have access to a telephone; and willing to complete baseline and follow-up telephone interviews.

排除标准

  • Women who are pregnant, breastfeeding or planning to become pregnant in the next six months will be excluded from this trial, as will current users of smoking cessation medications or those who are participating in another smoking cessation program or study. The current users of varenicline and cytisine, and those with known hypersensitivity to the active substance or to any of the excipients also will be excluded. People will also be excluded if they report any of the following medical conditions in the previous three months: arrhythmia, heart attack, stroke, or severe angina.People with pheochromocytoma and hyperthyroidism also will be excluded.

研究者

相似试验